Skip to main content

Table 6

From: Pre-exenterative chemotherapy, a novel therapeutic approach for patients with persistent or recurrent cervical cancer

Surgical morbidity Mean Range
Surgical time 6.3 4.3–8
Bleeding 1860 mL 600–1600
Units transfused 3.4 1–6
Hospital stay 11-7 6–41
Intensive Care Unit stay 1.8 0–12
   Complication (events)   
Intestinal occlusion 1 (11%)  
Massive bleeding 1 (11%)  
Urinary fistula 1 (11%)  
Perineal infection 2 (22%)  
Death 1 (11%)*  
  1. The patient died (fistula and infection) at 4 months post-exenteration. This patient had pathological complete response.
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us